Fibroblast activation protein (FAP) targeted RPT could deliver radiation dose to CAFs, not only killing CAFs and adjacent TNBC tumor cells, but also reducing the secretion of CXCL12 by CAFs. The gene discussed is FAP; the disease is neoplasm.